Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | CPT2 | P23786 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | ACLY | P53396 | 1/20 | 0.32 |
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
| ▸ | ACACA | Q13085 | 1/20 | 0.31 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11088264 | 0.91 | FFAR1 (0.48) | FFAR1CPT2TDP1CYP4F2CYP4A11 | |
| Gemcadiol SCHEMBL636304 | 0.91 | FFAR1 (0.48) | FFAR1CPT2TDP1CYP4F2CYP4A11 | |
| SCHEMBL11082433 | 0.91 | FFAR1 (0.48) | FFAR1CPT2TDP1CYP4F2CYP4A11 | |
| SCHEMBL6268365 | 0.91 | FFAR1 (0.48) | FFAR1CPT2TDP1CYP4F2CYP4A11 | |
| SCHEMBL6267734 | 0.91 | FFAR1 (0.48) | FFAR1CPT2TDP1CYP4F2CYP4A11 | |
| SCHEMBL11088869 | 0.91 | FFAR1 (0.48) | FFAR1CPT2TDP1CYP4F2CYP4A11 | |
| SCHEMBL6270199 | 0.88 | FFAR1 (0.43) | FFAR1CPT2TDP1 | |
| SCHEMBL28002575 | 0.83 | TDP1 (0.42) | FFAR1CPT2TDP1CYP4F2CYP4A11 | |
| SCHEMBL156985 | 0.83 | TDP1 (0.42) | FFAR1CPT2TDP1CYP4F2CYP4A11 | |
| 1,6-Hexanediol SCHEMBL8723953 | 0.83 | TDP1 (0.42) | FFAR1CPT2TDP1CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080226601-A1 | Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods | UNIVERSITY OF ROCHESTER (US) | 2008-09-18 | — | — | US | disclosed |
| EP-1903873-A2 | HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS | THE UNIVERSITY OF ROCHESTER (US) | 2008-04-02 | — | — | EP | disclosed |
| WO-2006135602-A2 | HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS | UNIVERSITY OF ROCHESTER (US) | 2006-12-21 | — | — | WO | disclosed |